Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Antibiotic Resistance and New Antimicrobial drugs

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1638577

This article is part of the Research TopicTuberculosis in Focus: Antibiotic Resistance and New Antimicrobial DrugsView all articles

Population structure and emergence of resistance to new and repurposed drugs in XDR-TB: Insights from a 10-year genomic study in the Western Cape, South Africa review

Provisionally accepted
  • 11. South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University,, Cape Town, South Africa
  • 22. South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Faculty of Medicine and Health Sciences, Stellenbosch University,, Cape Town, South Africa
  • 33. National Health Laboratory Service, Green Point TB-Laboratory,, Cape Town, South Africa

The final, formatted version of the article will be published soon.

Background: Extensively drug-resistant tuberculosis (XDR-TB) is a global health threat, being expensive and difficult to treat, with high mortality rates. The Western Cape Province (WCP), South Africa, has a particularly high burden of XDR-TB (>800 cases in the past ten years). Drug resistance genotypes and transmission present substantial regional variability. Thus, a better understanding of genetic diversity, clustering and the factors related to transmission can aid in prioritizing resources to effectively target high-risk populations and regions that are disproportionately affected.We describe genetic diversity, drug resistance profiles and identify potential factors associated with the spread of XDR-TB strains collected in the WCP.We included 729 XDR-TB samples (one per patient), identified through routine diagnosis spanning 2010 to 2019, from six healthcare districts (HCDs) in the WCP. Genomic DNA from cultured isolates was sequenced using the Illumina platform. Sequences were analysed for strain type, drug resistance mutations, and genomic clustering using the TBProfiler and MTBseq pipelines. We conducted logistic regression analysis to identify potential factors associated with genomic traits related to the spread of XDR-TB strains.Results: Of the 729 XDR-TB strains, sublineage 2.2.2 (Atypical Beijing: n=378, 58.79%) strains were predominant, followed by Sublineage 2.2.1 (Typical Beijing: n=260, 40.43%). Atypical Beijing strains were more likely to cluster than Typical Beijing strains. Most of the clusters were small, with a few large and very large clusters, and the strains within very large clusters (primarily Atypical Beijing) were more likely to be found within Cape Town Metropole, Cape Winelands and Garden Route HCDs.Certain Atypical Beijing strains were found resistant to new and repurposed drugs recently introduced in the WHO treatment guidelines and clustered, indicating potential transmission.Conclusions: Near-untreatable Atypical Beijing strains are prevalent in the WCP.Hence, hotspot areas for clustering in Cape Town Metropole, Cape Winelands and Garden Route HCDs should be prioritized for targeted intervention to prevent ongoing XDR-TB transmission.

Keywords: Genomic characterization, Extensively Drug-Resistant Tuberculosis, whole genome sequencing, transmission, new and repurposed drugs, South Africa

Received: 30 May 2025; Accepted: 12 Aug 2025.

Copyright: © 2025 Ngom, Loubser, Maasdorp, Ghebrekritos, Opperman, Klopper, Warren and Streicher. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Justice Tresor Ngom, 1. South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University,, Cape Town, South Africa
Elizabeth Streicher, 1. South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University,, Cape Town, South Africa

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.